Cargando…

The Natural Product Zerumbone Suppresses Pressure Overload-Induced Cardiac Dysfunction by Inhibiting Cardiac Hypertrophy and Fibrosis

Detalles Bibliográficos
Autores principales:	Tojima, Mikuto, Katanasaka, Yasufumi, Sunagawa, Yoichi, Hasegawa, Koji, Morimoto, Tatsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Radcliffe Cardiology 2021
Materias:	ISCP Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785086/ https://www.ncbi.nlm.nih.gov/pubmed/35106086 http://dx.doi.org/10.15420/ecr.2021.16.PO14

Ejemplares similares

Young Investigator Award: Compound A, a Ginger Extract, Significantly Reduces Pressure Overload-induced Systolic Heart Failure in Mice
por: Kawase, Yuto, et al.
Publicado: (2021)

Chrysanthemum morifolium Extract Prevents the Development of Doxorubicin-induced Heart Failure
por: Ono, Masaya, et al.
Publicado: (2021)

A Novel Curcumin Formulation, ASD-Cur, Suppressed the Development of Systolic Dysfunction After Myocardial Infarction in Rats
por: Takai, Hidemichi, et al.
Publicado: (2021)

The Polyunsaturated Fatty Acids EPA and DHA Prevent Myocardial Infarction-induced Heart Failure by Inhibiting p300-HAT Activity in Rats
por: Sunagawa, Yoichi, et al.
Publicado: (2021)

Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay
por: Shimizu, Satoshi, et al.
Publicado: (2021)

The Selective Serotonin 2A Receptor Antagonist Sarpogrelate Prevents Cardiac Hypertrophy and Systolic Dysfunction via Inhibition of the ERK1/2–GATA4 Signaling Pathway
por: Shimizu, Kana, et al.
Publicado: (2021)

6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure
por: Kawase, Yuto, et al.
Publicado: (2023)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Xu, Si-Chi, et al.
Publicado: (2017)

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
por: Guo, Xinji, et al.
Publicado: (2020)

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
Publicado: (2022)

Curcumin, an Inhibitor of p300-HAT Activity, Suppresses the Development of Hypertension-Induced Left Ventricular Hypertrophy with Preserved Ejection Fraction in Dahl Rats
por: Sunagawa, Yoichi, et al.
Publicado: (2021)

Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy
por: Ma, Sai, et al.
Publicado: (2021)

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies
por: Komiyama, Maki, et al.
Publicado: (2023)

IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Dai, Jia, et al.
Publicado: (2013)

The Synthetic Curcumin Analogue GO-Y030 Effectively Suppresses the Development of Pressure Overload-induced Heart Failure in Mice
por: Shimizu, Kana, et al.
Publicado: (2020)

The Role of Isocitrate Dehydrogenases in Direct Reprogramming to Cardiomyocytes
por: Ishida, Tomoaki, et al.
Publicado: (2021)

Oral Presentation Award Winner: β3 Adrenergic Receptors in the Sinoatrial Node for Heart Rate Regulation
por: Nakao, Shu, et al.
Publicado: (2021)

Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, and Fibrosis Induced by Pressure Overload
por: Zhou, Heng, et al.
Publicado: (2011)

Microtubule Stabilization in Pressure Overload Cardiac Hypertrophy
por: Sato, Hiroshi, et al.
Publicado: (1997)

MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload
por: Ji, Yue, et al.
Publicado: (2018)

Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex
por: Funamoto, Masafumi, et al.
Publicado: (2022)

A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study Protocol
por: Matsuda, M, et al.
Publicado: (2020)

TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice
por: Wang, Zhen, et al.
Publicado: (2018)

Posters from the 24th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy: Best Poster Award – First Prize: Network Meta-analysis to Determine the Optimal Level of Systolic Blood Pressure for Hypertensive Patients
por: Cheung, BMY, et al.
Publicado: (2020)

Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestyle-related Diseases
por: Shimizu, Kana, et al.
Publicado: (2019)

CBMS-3 SEARCH FOR COMPOUNDS WITH ANTI-TUMOUR EFFECTS AGAINST GLIOBLASTOMA
por: Iwashimizu, Sonoka, et al.
Publicado: (2022)

NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin
por: Yue, Rongchuan, et al.
Publicado: (2021)

Ecklonia stolonifera Okamura Extract Suppresses Myocardial Infarction-Induced Left Ventricular Systolic Dysfunction by Inhibiting p300-HAT Activity
por: Katagiri, Takahiro, et al.
Publicado: (2022)

Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload
por: Nordén, Einar Sjaastad, et al.
Publicado: (2021)

Intermedin Suppresses Pressure Overload Cardiac Hypertrophy through Activation of Autophagy
por: Chen, HuaLi, et al.
Publicado: (2013)

Effects of miRNA-455 on cardiac hypertrophy induced by pressure overload
por: WU, CHUNTAO, et al.
Publicado: (2015)

Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling
por: Liu, Xin, et al.
Publicado: (2021)

Celecoxib prevents pressure overload‐induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress
por: Zhang, Chi, et al.
Publicado: (2015)

C‐C Motif Chemokine Receptor 9 Exacerbates Pressure Overload–Induced Cardiac Hypertrophy and Dysfunction
por: Xu, Zhengxi, et al.
Publicado: (2016)

Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure
por: Jin, Li, et al.
Publicado: (2018)

Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice
por: Goh, Kah Yong, et al.
Publicado: (2019)

Endothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation
por: Salvador, Ane M., et al.
Publicado: (2017)

Adherence to Statin Therapy Drives Survival of Patients with Symptomatic Peripheral Artery Disease
por: Dopheide, J, et al.
Publicado: (2020)

Evaluation of the Effect of Heart Failure Reversal Therapy on Anthropometric Obesity Parameters in Patients with Chronic Heart Failure: A Retrospective Analysis
por: Sane, R
Publicado: (2020)

Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
por: Rizzo, M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_of06f72r82olvvfpjbhf7vqllm